HK1169424A1 - 用於免疫治療的 共有表位的鑒定、優化與應用 - Google Patents
用於免疫治療的 共有表位的鑒定、優化與應用Info
- Publication number
- HK1169424A1 HK1169424A1 HK12110232.3A HK12110232A HK1169424A1 HK 1169424 A1 HK1169424 A1 HK 1169424A1 HK 12110232 A HK12110232 A HK 12110232A HK 1169424 A1 HK1169424 A1 HK 1169424A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- hla
- immunotherapy
- epitopes
- optimization
- identification
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- G—PHYSICS
- G05—CONTROLLING; REGULATING
- G05D—SYSTEMS FOR CONTROLLING OR REGULATING NON-ELECTRIC VARIABLES
- G05D16/00—Control of fluid pressure
- G05D16/20—Control of fluid pressure characterised by the use of electric means
-
- G—PHYSICS
- G11—INFORMATION STORAGE
- G11C—STATIC STORES
- G11C13/00—Digital stores characterised by the use of storage elements not covered by groups G11C11/00, G11C23/00, or G11C25/00
- G11C13/02—Digital stores characterised by the use of storage elements not covered by groups G11C11/00, G11C23/00, or G11C25/00 using elements whose operation depends upon chemical change
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Fluid Mechanics (AREA)
- Automation & Control Theory (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2009/006332 WO2010143010A1 (en) | 2009-06-09 | 2009-06-09 | Identification, optimization and use of shared hla-b*0702 epitopes for immunotherapy |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1169424A1 true HK1169424A1 (zh) | 2013-01-25 |
Family
ID=41319617
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK12110232.3A HK1169424A1 (zh) | 2009-06-09 | 2012-10-17 | 用於免疫治療的 共有表位的鑒定、優化與應用 |
Country Status (11)
Country | Link |
---|---|
US (1) | US10024868B2 (zh) |
EP (1) | EP2440575B1 (zh) |
JP (1) | JP2012529283A (zh) |
CN (1) | CN102459322B (zh) |
BR (1) | BRPI0924556A2 (zh) |
CA (1) | CA2764760C (zh) |
ES (1) | ES2533228T3 (zh) |
HK (1) | HK1169424A1 (zh) |
PL (1) | PL2440575T3 (zh) |
PT (1) | PT2440575E (zh) |
WO (1) | WO2010143010A1 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230062674A (ko) | 2013-03-15 | 2023-05-09 | 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 | 암 백신 및 이를 이용한 치료 방법 |
EP2977059A1 (en) * | 2014-07-22 | 2016-01-27 | Vaxon Biotech | Immunogenic polypeptide composed of HLA-B7 restricted tumor antigen-derived optimized cryptic peptides, and uses thereof |
CA2984643A1 (en) | 2015-05-13 | 2016-11-17 | Agenus Inc. | Vaccines for treatment and prevention of cancer |
CN109476724B (zh) | 2016-04-08 | 2023-04-04 | 艾达普特免疫有限公司 | T细胞受体 |
RU2018138836A (ru) * | 2016-04-08 | 2020-05-12 | Адаптимьюн Лимитед | Т-клеточные рецепторы |
CA3096909A1 (en) | 2018-04-26 | 2019-10-31 | Agenus Inc. | Heat shock protein-binding peptide compositions and methods of use thereof |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6026A (en) * | 1849-01-09 | Cast-iron car-wheel | ||
US5734023A (en) * | 1991-11-19 | 1998-03-31 | Anergen Inc. | MHC class II β chain/peptide complexes useful in ameliorating deleterious immune responses |
US9340577B2 (en) * | 1992-08-07 | 2016-05-17 | Epimmune Inc. | HLA binding motifs and peptides and their uses |
AU7440196A (en) * | 1995-10-12 | 1997-04-30 | Chiron Corporation | Baboon mage-3 homologs, dna encoding the homologs, and a process for their use |
EP1235841A4 (en) * | 1999-12-10 | 2006-04-12 | Epimmune Inc | TRIGGERING MAGE2 / 3 CELLULAR IMMUNE RESPONSES USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS |
WO2003008537A2 (en) * | 2001-04-06 | 2003-01-30 | Mannkind Corporation | Epitope sequences |
US20040142325A1 (en) * | 2001-09-14 | 2004-07-22 | Liat Mintz | Methods and systems for annotating biomolecular sequences |
FR2837837B1 (fr) | 2002-03-28 | 2006-09-29 | Roussy Inst Gustave | Epitopes peptidiques communs a des antigenes d'une meme famille multigenique |
CN100418981C (zh) * | 2002-06-10 | 2008-09-17 | 瓦西尼斯公司 | 在乳腺癌和膀胱癌中差异表达的基因及编码多肽 |
WO2008010010A1 (en) * | 2006-07-12 | 2008-01-24 | Vaxon Biotech | Identification, optimization and use of cryptic hla-b7 epitopes for immunotherapy |
US7698688B2 (en) * | 2008-03-28 | 2010-04-13 | International Business Machines Corporation | Method for automating an internationalization test in a multilingual web application |
WO2010037395A2 (en) * | 2008-10-01 | 2010-04-08 | Dako Denmark A/S | Mhc multimers in cancer vaccines and immune monitoring |
-
2009
- 2009-06-09 ES ES09786052.2T patent/ES2533228T3/es active Active
- 2009-06-09 WO PCT/IB2009/006332 patent/WO2010143010A1/en active Application Filing
- 2009-06-09 CN CN200980160568.7A patent/CN102459322B/zh active Active
- 2009-06-09 PT PT97860522T patent/PT2440575E/pt unknown
- 2009-06-09 JP JP2012514541A patent/JP2012529283A/ja active Pending
- 2009-06-09 BR BRPI0924556-1A patent/BRPI0924556A2/pt not_active Application Discontinuation
- 2009-06-09 CA CA2764760A patent/CA2764760C/en active Active
- 2009-06-09 EP EP09786052.2A patent/EP2440575B1/en active Active
- 2009-06-09 US US13/377,091 patent/US10024868B2/en active Active
- 2009-06-09 PL PL09786052T patent/PL2440575T3/pl unknown
-
2012
- 2012-10-17 HK HK12110232.3A patent/HK1169424A1/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ES2533228T3 (es) | 2015-04-08 |
WO2010143010A1 (en) | 2010-12-16 |
EP2440575B1 (en) | 2014-11-05 |
US20120142894A1 (en) | 2012-06-07 |
CA2764760A1 (en) | 2010-12-16 |
CN102459322B (zh) | 2015-11-25 |
CN102459322A (zh) | 2012-05-16 |
CA2764760C (en) | 2019-11-26 |
US10024868B2 (en) | 2018-07-17 |
PL2440575T3 (pl) | 2015-04-30 |
JP2012529283A (ja) | 2012-11-22 |
BRPI0924556A2 (pt) | 2015-06-30 |
PT2440575E (pt) | 2015-02-12 |
EP2440575A1 (en) | 2012-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL251697A0 (en) | Antibodies against 3erbb and their uses | |
PL2413956T3 (pl) | Identyfikacja, optymalizacja oraz zastosowanie kryptycznych epitopów antygenu hla-a24 na potrzeby immunoterapii | |
EP2429585A4 (en) | VACCINE IMMUNOTHERAPY | |
EP2762488A4 (en) | PEPTIDE FOR SYNTHESIS OF SILICA AND USE THEREOF | |
ZA201208290B (en) | Anti-erbb3 antibodies | |
EP2530091A4 (en) | ANTIBODY ANTI-DLL3 | |
IL225667A0 (en) | A new antigen | |
EP2636736A4 (en) | NOVEL ANTI-DR5 ANTIBODY | |
GB2469177B (en) | Shoulder rest | |
SI2630174T1 (sl) | Vodni pripravki, ki imajo lastnosti mehkega otipa | |
HK1170745A1 (zh) | 的抗體 | |
HRP20190289T1 (hr) | Protutijela protiv antigena specifičnog za matične stanice prostate i njihova upotreba | |
HK1169424A1 (zh) | 用於免疫治療的 共有表位的鑒定、優化與應用 | |
EP2575888A4 (en) | NASAL IMMUNIZATION | |
GB201018557D0 (en) | Method & apparatus -seal-less valve | |
PT2635159E (pt) | Apoio de cabeça | |
HK1178519A1 (zh) | 美他沙酮共晶體 | |
IL223436A (en) | Methods for preparing tetranor - pgdm and tetranor - pgjm | |
EP2602770A4 (en) | IDENTIFICATION PAPER | |
GB201007957D0 (en) | Antibody | |
PL392488A1 (pl) | Sposób jednoczesnego wytwarzania 3ß,7α-dihydroksyandrost-5-en-17-onu i 3ß,7ß-dihydroksyandrost-5-en-17-onu | |
GB201004155D0 (en) | Shoulder rest | |
GB0905547D0 (en) | Shoulder rest | |
GB201000492D0 (en) | K&Rimp | |
GB201017780D0 (en) | Antibody |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20200608 |